Company: FVN
Filing Date: 2025-05-30
Form Type: S-4/A
Source: 0001829126-25-004067
Chunk: 560

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-05-30
Form: S-4/A
Chunk 560
---
 addressed in accordance with the applicable provisions of Cayman
Law. If the Company is unable to complete an initial Business Combination within the required time period and the Company liquidates
the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they
receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights
will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon
consummation of an initial Business Combination. Accordingly, the rights may expire worthless.

Note 7 — Commitments &Contingencies

Registration Rights

The holders of the Founder Shares and Private
Placement Units (and their underlying securities) are entitled to registration rights pursuant to the registration rights agreement signed
on the effective date of the IPO, requiring the Company to register such securities for resale. The holders of these securities are entitled
to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have
certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the
initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under
the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

<div align='center'>F-36</div>

<div align='center'>FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

March 31, 2025</div>

Underwriting Agreement

The Company granted the underwriters a 45-day
option from the effective date of the IPO to purchase up to an additional 750,000 units to cover over-allotments at the IPO price. On
September 13, 2024, the over-allotment options were exercised, generating gross proceeds of $7,500,000 and deposited into the Trust
Account.

The underwriters were entitled to an underwriting
discount of 4.0% of the gross proceeds of the IPO, of which (i) 1.5% of the gross proceeds of the IPO, or $862,500, were paid in cash
at the closing of the IPO, (ii) 57,500 ordinary shares were paid at the closing of the IPO as representative shares (“Representative
Shares